It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: baddmove
The WHO ,not the band, is recommending we all get the imvanex vaccine to help stop monkeypox.
There are over 17,000 cases reported from 80 countries and who knows how many aren't.
It's coming in fast folks so bust out your... well, I'm not sure what we will have to wear on this one.
here's a link to the live updates to keep you all up on how fast it's coming in.
good luck everyone!
www.monkeypoxmeter.com...
originally posted by: Nothin
originally posted by: baddmove
The WHO ,not the band, is recommending we all get the imvanex vaccine to help stop monkeypox.
There are over 17,000 cases reported from 80 countries and who knows how many aren't.
It's coming in fast folks so bust out your... well, I'm not sure what we will have to wear on this one.
here's a link to the live updates to keep you all up on how fast it's coming in.
good luck everyone!
www.monkeypoxmeter.com...
Would like to inquire about your source.
Who own MonkeyPoxMeter.Com™ ?
Who are their financial backers, parent companies ?
Where do they get their info from ?
Give us a reason to believe it ?
Humanity still isn't walking right, since having the last (PHEIC™) Fake™ Plandemic being shoved-up our collective rear-bumpers.
Public Health Emergency of International Concern™ (PHEIC™), is pronounced : Fake™.
originally posted by: Joneselius
Imagine what this is going to do to those who took the mark and now have no immune system?
Greivious boils anyone?
RESULTS
Vaccinated participants maintained antivaccinia IgG and neutralizing antibody titers above 3 natural logs essentially indefinitely. The absolute titer of antivaccinia antibody was only slightly higher after multiple vaccinations. In 97% of the participants, no decrease in vaccinia-specific antibody titers was noted with age over a follow-up period of up to 88 years. Moreover, Baltimore Longitudinal Study of Aging participants who survived active smallpox infections in their youth retained antivaccinia antibody titers that were similar to the levels detected in vaccinated subjects.
CONCLUSION
These data suggest that multiple or recent vaccinations are not essential to maintain vaccinia-specific antibody responses in human subjects. Scarce vaccine supplies should be applied first to individuals who have not previously been vaccinated.
originally posted by: infolurker
a reply to: baddmove
Strangely, I have seen "Recent Articles" reference smallpox vaccines are only good for 3-5 years? Doesn't makes sense does it? For decades, once was enough and even studies show that immunity lasts decades but now something changed. Could it be someone needs to make money every 3-5 years?
Hmmmmm... that is strange now isn't it?
originally posted by: beyondknowledge
originally posted by: infolurker
a reply to: baddmove
Strangely, I have seen "Recent Articles" reference smallpox vaccines are only good for 3-5 years? Doesn't makes sense does it? For decades, once was enough and even studies show that immunity lasts decades but now something changed. Could it be someone needs to make money every 3-5 years?
Hmmmmm... that is strange now isn't it?
Have you considered that they might have a newer and improvider smallpox every 3 to 5 years now?
originally posted by: Nothin
a reply to: Wizzz0001
Thanks.
Was asking, because my quick 5-minute search also turned-up empty.
But it looks Scmientific™ eh ?
All those Stats™ !!
Must be nothing but the Truth™ !
It is hard to believe that FDA gave this vaccine a license when you read the FDA reviewers' comments in their own report, below. They could not test the vaccine for efficacy against smallpox because there is no smallpox, nor against monkeypox because the disease is so rare. So the FDA relied on neutralizing antibody titers. But at the same time, FDA admitted there is no established correlate of protection. This means that there is no evidence that the titers represent actual immunity to infection. So FDA relied on animal studies to simply guess the vaccine might be effective in humans.
If you read my post on Monkeypox, published yesterday, you would know that I looked over the 200 page FDA licensure review of the Jynneos smallpox-monkeypox vaccine. That is where I discovered that 2 studies of Jynneos found that 11% in one and and 18% of recipients in the other had developed elevated levels of cardiac enzymes (troponin). This implies heart muscle damage of some kind. It was not studied further, and the reviewers admitted they did not know whether myocarditis was caused by the Jynneos vaccine, or not. And that they would need to perform future surveillance to find out.
This suggests that all those men who receive the vaccine now will be the guinea pigs, the first humans to determine if there is protection, and what the risks may be. Gay and bisexual men in their 20s and 30s will probably be at the highest risk of myocarditis, since males in this age group are at the highest risk of myocarditis from COVID mRNA vaccines.
It is they in whom it will be determined whether elevated cardiac enzymes, seen in two trials in up to 1 in 5 Jynneos vaccine recipients, are associated with cases of myocarditis, pericarditis, hart failure, arrhythmias or heart attacks. Then again, assuming FDA and CDC follow the COVID playbook, this serious side effect is likely to get missed, and sudden deaths in recipients may simply be brushed under the rug.